Midazolam in Total Intravenous Anaesthesia. Pharmacodynamic and Pharmacokinetic Aspects

  • A. Nilsson
  • M. P. Persson
  • P. Hartvig
Conference paper
Part of the Anaesthesiologie und Intensivmedizin / Anaesthesiology and Intensive Care Medicine book series (A+I, volume 206)


The history of intravenous anaesthesia goes back to 1665 when Sir Christopher Wren [20] published his experiments on the injection of opium into a ligated vein of a dog using a quill and a bladder as syringe. He reported “the success was that opium, being soon circulated into the brain, did within a short time stupify, though not kill the dog”. Intravenous anaesthesia had thus been described and a continuous search for agents with suitable pharmacodynamic and pharmacokinetic properties was initiated. The safe use of intravenous anaesthesia developed not only from research work but also from the many incidents that occurred during these early days. One of the most dramatic examples of this was the seemingly indiscriminate use of barbiturates in casualities following the Japanese raid on Pearl Harbour in 1941 [3]. The drugs used, thiopentone and hexobarbitone, were described as “an ideal form of euthanasia”.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boidin MP (1985) Serum levels of cortisol during etomidate, fentanyl and air anaesthesia, compared with neurolept anaesthesia. Acta Anaesthesiol Belgica 2:79Google Scholar
  2. 2.
    Dundee JW, Mc Murray TJ (1984) Clinical aspects of total intravenous anaesthesia: discussion paper. J Royal Soc Med 77:669Google Scholar
  3. 3.
    Halford FJ (1947) A critique of intravenous anesthesia in war surgery. Anesthesiology 4:67CrossRefGoogle Scholar
  4. 4.
    Klotz U, Ziegler G, Ludwig L, Reimann IW (1985) Pharmacodynamic interaction between midazolam and a specific benzodiazepine antagonist in humans. J Clin Pharmacol 25:400PubMedGoogle Scholar
  5. 5.
    Klotz U, Ziegler G, Raimann IW (1984) Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol 27:115PubMedGoogle Scholar
  6. 6.
    Lauven PM, Schwilden H, Stoeckel H, Greenblatt DJ (1985) The effects of a benzodiazepine antagonist Ro 15–1788 in the presence of stable concentrations of midazolam. Anesthesiology 63:61PubMedCrossRefGoogle Scholar
  7. 7.
    Ledingham I Mca, Watt I (1983) Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1:1270PubMedCrossRefGoogle Scholar
  8. 8.
    Moore RA, Allen MC, Wood PJ, Rees LH, Sear JW (1985) Peri-operative endocrine effects of etomidate. Anaesthesia 40:124PubMedCrossRefGoogle Scholar
  9. 9.
    Möller JT, Lybecker H (1986) In: Beitr Anaesth Intensivmed VII European Congress of Anaesthesiology Abstract 780. Maudrich, Wien München BernGoogle Scholar
  10. 10.
    Nilsson A, Persson MP, Hartvig P (to be published) Effects of the benzodiazepine antagonist Ro 15–1788 on postoperative performance following total intravenous anaesthesia using midazolam and alfentanil. Acta Anaesthiol ScandGoogle Scholar
  11. 11.
    Nilsson A, Persson MP, Hartvig P, Wide L (to be published) Effect of total intravenous anaesthesia using midazolam/alfentanil on the adrenocortical and hyperglycaemic response to abdominal surgery. Acta Anaesthesiol ScandGoogle Scholar
  12. 12.
    O’Boyle C, Lambe R, Darragh A, Taffe W, Brick I, Kenny M (1983) Ro 15–1788 antagonizes the effects of diazepam in man without affecting its bio-availability. Br J Anaesth 55:349PubMedCrossRefGoogle Scholar
  13. 13.
    Persson MP, Nilsson A, Hartvig P, Tamsen A (1987) Pharmacokinetics of midazolam in total intravenous anaesthesia. Br J Anaesth 59:548PubMedCrossRefGoogle Scholar
  14. 14.
    Persson MP, Nilsson A, Hartvig P (to be published) Pharmacokinetics of alfentanil in total intravenous anaesthesia. Br J AnaesthGoogle Scholar
  15. 15.
    Persson MP, Nilsson A, Hartvig P (to be published) Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol TherGoogle Scholar
  16. 16.
    Ricou B, Forster A, Brückner A, Chastonay P, Gemperle M (1986) Clinical evaluation of a specific benzodiazepine antagonist (Ro 15-1788). Br J Anaesth 58:1005PubMedCrossRefGoogle Scholar
  17. 17.
    Sear JW (1983) General kinetic and dynamic principles and their application to continuous infusion anaesthesia. Anaesthesia 38 Suppl 10Google Scholar
  18. 18.
    Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D (1984) Inhibition of adrenal steroido-genesis by the anesthetic etomidate. N Engl J Med 310:1415PubMedCrossRefGoogle Scholar
  19. 19.
    Wolff J, Clausen TG, Mikkelsen BO (1986) Ro 15–1788 for postoperative recovery. Anaesthesia 41:1001PubMedCrossRefGoogle Scholar
  20. 20.
    Wren PC. In: Philosophical transactions. Vol I for ANNO 1665 and 1666. London: Printed by T. N. for John Martyn at the BellGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • A. Nilsson
  • M. P. Persson
  • P. Hartvig

There are no affiliations available

Personalised recommendations